Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_assertion type Assertion NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_head.
- NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_assertion description "[We examined the effects of the mammalian target of rapamycin inhibitor, rapamycin, on mammary tumorigenesis in transgenic mice bearing an activated ErbB2 (NeuYD) transgene in the absence or presence of a second transgene encoding vascular endothelial growth factor (VEGF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_provenance.
- NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_assertion evidence source_evidence_literature NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_provenance.
- NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_assertion SIO_000772 15958580 NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_provenance.
- NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_assertion wasDerivedFrom befree-20140225 NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_provenance.
- NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_assertion wasGeneratedBy ECO_0000203 NP579017.RAu_0AvvROWgQS-l_3qgvfFrycJWkfIZBD5WqHk60IQWk130_provenance.